Women should have access to the medicines they need to live their best and fullest lives. Medicines360 is helping in a unique way.


Latest Updates

Press Releases

Medicines360 Appoints Elizabeth Garner, M.D., M.P.H. to Board of Directors 

SAN FRANCISCO – May 12, 2022 – Medicines360, the mission-driven nonprofit women’s health pharmaceutical organization, has appointed Elizabeth Garner MD, MPH, as a member of its Board of Directors, effective immediately. With over a decade of pharmaceutical development experience, Dr. Garner brings expansive knowledge in regulatory and clinical affairs, and a deep commitment to increasing […]

Read More >
Press Releases

Medicines360, Population Services International, and Society for Family Health Announce Launch of Avibela® Hormonal Intrauterine Device in Nigeria

Improving Access to Modern Contraception for Women in Nigeria  SAN FRANCISCO, WASHINGTON and ABUJA– March 22, 2022– Medicines360, Population Services International (PSI), and Society for Family Health (SFH) announced the launch of Avibela (levonorgestrel-releasing intrauterine system) 52 mg in Nigeria. Nigerian women and girls’ contraceptive options have historically been limited. The introduction of Avibela provides […]

Read More >
more updates

how we work

We’re reinventing the pharma business model: we identify areas in women’s health where patients face limited choices, develop medicines that expand women’s options and make them available in ways that close gaps in access.


We believe women should have access to medicines, regardless of their diverse needs. As we choose products for development and study them in robust clinical trials, we tackle areas where many women struggle with limited medicine choices.